PierianDx key facts
- Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process.
- PierianDx’s last known valuation is $133.0M (Aug 2020).
- It has raised $116.0M across 3 recorded rounds; the latest was Early Stage VC ($17.0M) in Jun 2021.
- Notable investors include Washington University in St. Louis, Frazier VC.
- PierianDx has filed 3 Form Ds with the SEC since 2018, most recently Nov 2021 ($17.0M sold to 13 investors).
- Status: Acquired/Merged (Operating Subsidiary).
Who backs PierianDx
2- ·Watch PierianDx: the Monday email on marks, rounds and moves
PierianDx funding rounds
3 roundsPierianDx valuation
PierianDx's last known valuation is $133 million, from Aug 2020. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has PierianDx raised?
PierianDx has raised $116 million in total; 3 of its rounds are on record, from 2018 on. The largest on record was a $3 million seed round in Jan 2018; the most recent was a $17 million early-stage round in Jun 2021.
PierianDx has filed 3 Form Ds with the SEC since 2018, most recently in Nov 2021 ($17 million sold to 13 investors).
PierianDx investors
2 investors are on record for PierianDx, including Washington University in St. Louis and Frazier VC. The early-stage round in Jun 2021 drew 13 investors.
About PierianDx
Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process. The company's software uses artificial intelligence to automate the process of taking DNA sequencing data through analysis, interpretation and final report, thereby empowering physicians in the laboratory and clinic to effectively diagnose and treat patients with cancer and other complex diseases.
- Sector
- Healthcare
- HQ
- Creve Coeur, MO, United States
- Founded
- 2014
- Employees
- 320
- Website
- pieriandx.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
PierianDx’s last known valuation, Aug 2020. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.